Cara Partners is a pharmaceutical manufacturer specializing in the production of a standardized extract of Ginkgo Biloba, which serves as an Active Pharmaceutical Ingredient (API). The company operates from its facility located in Little Island, County Cork, Ireland, where it has been producing this extract on a large scale since 1978. The choice of Ireland as a manufacturing base is strategic, leveraging the country's membership in the European Union and its reputation for a well-educated workforce, which contributes to the high standards of production and quality assurance in the pharmaceutical industry.

As part of the Schwabe Group of Germany, Cara Partners emphasizes the importance of scientific rigor and quality in its manufacturing processes. The company’s commitment to excellence is reflected in its adherence to industry standards and regulations, ensuring that its Ginkgo Biloba extract meets the necessary specifications for pharmaceutical applications. This focus on quality and compliance positions Cara Partners as a reliable supplier in the bulk pharmaceutical market, catering to the needs of various clients within the industry.

Ireland

Cara Partners is a pharmaceutical manufacturing company that specializes in producing a standardised extract of Ginkgo Biloba, an Active Pharmaceutical Ingredient (API), in County Cork, Ireland.

Cara Partners (Ipsen)

Company Details